Abstract
The eye is a major target for stem cell transplantation therapy because of the preponderance of eye illness, providing both good surgical accessibility and the ability to visually monitor changes following transplantation. Risks of extension and tumor development after intraocular stem cell transplantation can be controlled using laser ablation and, in severe situations, evisceration or enucleation. Additionally, cutting-edge techniques exist for evaluating the clinical significance of eye tissue transplant results.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
